Organization
Nuance Pharma
3 clinical trials
Clinical trial
A Phase 1, Open-label Pharmacokinetic Study of Intravenous NTM-001 (A Novel Formulation of Ketorolac Tromethamine Applied by Continuous Intravenous Infusion From A Pre-Mixed Bag) in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2022-07-05
Clinical trial
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
A Phase 1, Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Nebulized Ensifentrine in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2023-04-18